Please provide your email address to receive an email when new articles are posted on . Age, nulliparity, polyps and shorter sampling intervals may predict endometrial hyperplasia and cancer. Risk ...

August 4, 2010 — Women with complex or atypical endometrial hyperplasia who are prescribed progestin have a 3- to 5-fold diminished risk for the development of endometrial cancer. Hysterectomy risk is ...

Although it might seem reasonable to pronounce women cured after their endometrial hyperplasia regresses from hormonal treatment, researchers caution that long-term monitoring for relapse and cancer ...

Women with atypical endometrial hyperplasia have an increased risk of developing cancer Researchers from the University of Edinburgh have revealed that improved patient care is needed to reduce cancer ...

Several studies have investigated the mechanisms involved in progestin resistance. Decreased availability of progestin receptors before treatment or alterations in progestin receptor regulatory ...

The p160 steroid receptor cofactor (SRC) family of coactivators can modulate both ER and PR activity; however, it has recently been demonstrated that in the mouse uterus, SRC-1 is the preferred ...

Phase I Pharmacologic and Biologic Study of Ramucirumab (IMC-1121B), a Fully Human Immunoglobulin G1 Monoclonal Antibody Targeting the Vascular Endothelial Growth Factor Receptor-2 We conducted a case ...

An oral dose of 100 mg progesterone in a bioidentical hormone therapy combination that includes estradiol is sufficient to counteract potential estrogenic stimulation of the endometrium while ...

In 2012, 527,600 women worldwide were diagnosed with endometrial cancer. 1 The mortality rate was 1.7 to 2.4 per 100,000 women. In 2017, there will be an estimated 61,380 cases of endometrial cancer ...

A woman's microbiome may signal if cancer is lurking in her body, a small new study suggests. In the study, researchers at the Mayo Clinic looked at the microbes found in women's reproductive tracts, ...